Figure 2 | Scientific Reports

Figure 2

From: Prediction of survival in patients with advanced, refractory colorectal cancer in treatment with trifluridine/tipiracil: real-world vs clinical trial data

Figure 2The alternative text for this image may have been generated using AI.

Kapplan Meier OS and PFS curves according to groups of the RECOURSE clinical trial. (A) Kapplan Meier OS and PFS curves according to group of good vs poor prognostic characteristics; (B) Kapplan Meier OS and PFS curves of indolent (time since diagnosis of metastasis ≥ 18 months) vs aggressive disease (time since diagnosis of metastasis < 18 months); (C) Kapplan Meier OS and PFS curves of the groups of low (< 3 metastatic sites) vs high (≥ 3) tumor burden. Abbreviations: OS, overall survival; PFS, progression-free survival; mets, metastases.

Back to article page